March 16, 2020: NIH Announces Guidance for Clinical Trials Affected by COVID-19 Emergency

The NIH today announced new guidance describing the flexibility available to recipients who are conducting NIH-funded clinical trials or human subject studies affected by the COVID-19 public health emergency. The new guidance addresses the safety of research participants and research staff, delays in research progress, and unanticipated costs.

Last week, the NIH created a new public web page—Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients—to serve as a central location for information about application deadlines, proposal submission and award management, and flexibility available to applicants and recipients. The page also includes links to COVID-19 information from the NIH, the Centers for Disease Control and Prevention, and the World Health Organization. The web page will be updated as events require.